RBC Capital raised the firm’s price target on Extendicare (EXETF) to C$30 from C$25 and keeps an Outperform rating on the shares.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on EXETF:
- Extendicare Inc. Showcases Strong Growth in Earnings Call
- Extendicare boosts earnings, raises dividend and doubles down on home health with $570 million CBI deal
- EXE Earnings this Week: How Will it Perform?
- Extendicare declares February 2026 monthly dividend of C$0.042 per share
- Extendicare Sets Date for Q4 2025 Results and Investor Call